This report contains market size and forecasts of Intravenous (IV) Solution in global, including the following market information:
Global Intravenous (IV) Solution Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Intravenous (IV) Solution Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Intravenous (IV) Solution companies in 2020 (%)
The global Intravenous (IV) Solution market was valued at 7922.8 million in 2020 and is projected to reach US$ 9330.3 million by 2027, at a CAGR of 4.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravenous (IV) Solution manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous (IV) Solution Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Intravenous (IV) Solution Market Segment Percentages, By Type, 2020 (%)
Total Parenteral Solution
Peripheral Parenteral Solution
Global Intravenous (IV) Solution Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Intravenous (IV) Solution Market Segment Percentages, By Application, 2020 (%)
Hospitals & Clinics
Ambulatory
Homecare
Global Intravenous (IV) Solution Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Intravenous (IV) Solution Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous (IV) Solution revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Intravenous (IV) Solution revenues share in global market, 2020 (%)
Key companies Intravenous (IV) Solution sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Intravenous (IV) Solution sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Intravenous (IV) Solution Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intravenous (IV) Solution Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intravenous (IV) Solution Overall Market Size
2.1 Global Intravenous (IV) Solution Market Size: 2021 VS 2027
2.2 Global Intravenous (IV) Solution Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Intravenous (IV) Solution Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Intravenous (IV) Solution Players in Global Market
3.2 Top Global Intravenous (IV) Solution Companies Ranked by Revenue
3.3 Global Intravenous (IV) Solution Revenue by Companies
3.4 Global Intravenous (IV) Solution Sales by Companies
3.5 Global Intravenous (IV) Solution Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Intravenous (IV) Solution Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Intravenous (IV) Solution Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intravenous (IV) Solution Players in Global Market
3.8.1 List of Global Tier 1 Intravenous (IV) Solution Companies
3.8.2 List of Global Tier 2 and Tier 3 Intravenous (IV) Solution Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Intravenous (IV) Solution Market Size Markets, 2021 & 2027
4.1.2 Total Parenteral Solution
4.1.3 Peripheral Parenteral Solution
4.2 By Type - Global Intravenous (IV) Solution Revenue & Forecasts
4.2.1 By Type - Global Intravenous (IV) Solution Revenue, 2016-2021
4.2.2 By Type - Global Intravenous (IV) Solution Revenue, 2022-2027
4.2.3 By Type - Global Intravenous (IV) Solution Revenue Market Share, 2016-2027
4.3 By Type - Global Intravenous (IV) Solution Sales & Forecasts
4.3.1 By Type - Global Intravenous (IV) Solution Sales, 2016-2021
4.3.2 By Type - Global Intravenous (IV) Solution Sales, 2022-2027
4.3.3 By Type - Global Intravenous (IV) Solution Sales Market Share, 2016-2027
4.4 By Type - Global Intravenous (IV) Solution Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Intravenous (IV) Solution Market Size, 2021 & 2027
5.1.2 Hospitals & Clinics
5.1.3 Ambulatory
5.1.4 Homecare
5.2 By Application - Global Intravenous (IV) Solution Revenue & Forecasts
5.2.1 By Application - Global Intravenous (IV) Solution Revenue, 2016-2021
5.2.2 By Application - Global Intravenous (IV) Solution Revenue, 2022-2027
5.2.3 By Application - Global Intravenous (IV) Solution Revenue Market Share, 2016-2027
5.3 By Application - Global Intravenous (IV) Solution Sales & Forecasts
5.3.1 By Application - Global Intravenous (IV) Solution Sales, 2016-2021
5.3.2 By Application - Global Intravenous (IV) Solution Sales, 2022-2027
5.3.3 By Application - Global Intravenous (IV) Solution Sales Market Share, 2016-2027
5.4 By Application - Global Intravenous (IV) Solution Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Intravenous (IV) Solution Market Size, 2021 & 2027
6.2 By Region - Global Intravenous (IV) Solution Revenue & Forecasts
6.2.1 By Region - Global Intravenous (IV) Solution Revenue, 2016-2021
6.2.2 By Region - Global Intravenous (IV) Solution Revenue, 2022-2027
6.2.3 By Region - Global Intravenous (IV) Solution Revenue Market Share, 2016-2027
6.3 By Region - Global Intravenous (IV) Solution Sales & Forecasts
6.3.1 By Region - Global Intravenous (IV) Solution Sales, 2016-2021
6.3.2 By Region - Global Intravenous (IV) Solution Sales, 2022-2027
6.3.3 By Region - Global Intravenous (IV) Solution Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Intravenous (IV) Solution Revenue, 2016-2027
6.4.2 By Country - North America Intravenous (IV) Solution Sales, 2016-2027
6.4.3 US Intravenous (IV) Solution Market Size, 2016-2027
6.4.4 Canada Intravenous (IV) Solution Market Size, 2016-2027
6.4.5 Mexico Intravenous (IV) Solution Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Intravenous (IV) Solution Revenue, 2016-2027
6.5.2 By Country - Europe Intravenous (IV) Solution Sales, 2016-2027
6.5.3 Germany Intravenous (IV) Solution Market Size, 2016-2027
6.5.4 France Intravenous (IV) Solution Market Size, 2016-2027
6.5.5 U.K. Intravenous (IV) Solution Market Size, 2016-2027
6.5.6 Italy Intravenous (IV) Solution Market Size, 2016-2027
6.5.7 Russia Intravenous (IV) Solution Market Size, 2016-2027
6.5.8 Nordic Countries Intravenous (IV) Solution Market Size, 2016-2027
6.5.9 Benelux Intravenous (IV) Solution Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Intravenous (IV) Solution Revenue, 2016-2027
6.6.2 By Region - Asia Intravenous (IV) Solution Sales, 2016-2027
6.6.3 China Intravenous (IV) Solution Market Size, 2016-2027
6.6.4 Japan Intravenous (IV) Solution Market Size, 2016-2027
6.6.5 South Korea Intravenous (IV) Solution Market Size, 2016-2027
6.6.6 Southeast Asia Intravenous (IV) Solution Market Size, 2016-2027
6.6.7 India Intravenous (IV) Solution Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Intravenous (IV) Solution Revenue, 2016-2027
6.7.2 By Country - South America Intravenous (IV) Solution Sales, 2016-2027
6.7.3 Brazil Intravenous (IV) Solution Market Size, 2016-2027
6.7.4 Argentina Intravenous (IV) Solution Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Intravenous (IV) Solution Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Intravenous (IV) Solution Sales, 2016-2027
6.8.3 Turkey Intravenous (IV) Solution Market Size, 2016-2027
6.8.4 Israel Intravenous (IV) Solution Market Size, 2016-2027
6.8.5 Saudi Arabia Intravenous (IV) Solution Market Size, 2016-2027
6.8.6 UAE Intravenous (IV) Solution Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 ICU Medical
7.1.1 ICU Medical Corporate Summary
7.1.2 ICU Medical Business Overview
7.1.3 ICU Medical Intravenous (IV) Solution Major Product Offerings
7.1.4 ICU Medical Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.1.5 ICU Medical Key News
7.2 B. Braun Melsungen
7.2.1 B. Braun Melsungen Corporate Summary
7.2.2 B. Braun Melsungen Business Overview
7.2.3 B. Braun Melsungen Intravenous (IV) Solution Major Product Offerings
7.2.4 B. Braun Melsungen Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.2.5 B. Braun Melsungen Key News
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Corporate Summary
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Intravenous (IV) Solution Major Product Offerings
7.3.4 Fresenius Kabi Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.3.5 Fresenius Kabi Key News
7.4 Baxter
7.4.1 Baxter Corporate Summary
7.4.2 Baxter Business Overview
7.4.3 Baxter Intravenous (IV) Solution Major Product Offerings
7.4.4 Baxter Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.4.5 Baxter Key News
7.5 Amanta Healthcare
7.5.1 Amanta Healthcare Corporate Summary
7.5.2 Amanta Healthcare Business Overview
7.5.3 Amanta Healthcare Intravenous (IV) Solution Major Product Offerings
7.5.4 Amanta Healthcare Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.5.5 Amanta Healthcare Key News
7.6 Terumo Medical
7.6.1 Terumo Medical Corporate Summary
7.6.2 Terumo Medical Business Overview
7.6.3 Terumo Medical Intravenous (IV) Solution Major Product Offerings
7.6.4 Terumo Medical Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.6.5 Terumo Medical Key News
7.7 Grifols
7.7.1 Grifols Corporate Summary
7.7.2 Grifols Business Overview
7.7.3 Grifols Intravenous (IV) Solution Major Product Offerings
7.4.4 Grifols Intravenous (IV) Solution Sales and Revenue in Global (2016-2021)
7.7.5 Grifols Key News
8 Global Intravenous (IV) Solution Production Capacity, Analysis
8.1 Global Intravenous (IV) Solution Production Capacity, 2016-2027
8.2 Intravenous (IV) Solution Production Capacity of Key Manufacturers in Global Market
8.3 Global Intravenous (IV) Solution Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Intravenous (IV) Solution Supply Chain Analysis
10.1 Intravenous (IV) Solution Industry Value Chain
10.2 Intravenous (IV) Solution Upstream Market
10.3 Intravenous (IV) Solution Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Intravenous (IV) Solution Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Intravenous (IV) Solution in Global Market
Table 2. Top Intravenous (IV) Solution Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Intravenous (IV) Solution Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Intravenous (IV) Solution Revenue Share by Companies, 2016-2021
Table 5. Global Intravenous (IV) Solution Sales by Companies, (K Units), 2016-2021
Table 6. Global Intravenous (IV) Solution Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Intravenous (IV) Solution Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Intravenous (IV) Solution Product Type
Table 9. List of Global Tier 1 Intravenous (IV) Solution Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous (IV) Solution Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type